Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML

NCT00529880 is registered in ClinicalTrials.gov with Cooperative Study Group A for Hematology as lead sponsor.

NCT NCT00529880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00529880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML
Lead sponsor
Cooperative Study Group A for Hematology
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2004
Completion date
October 31, 2007
Enrollment
19 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia